Sangamo Therapeutics (SGMO) Appoints Karen Smith to its Board of Directors
Tweet Send to a Friend
Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the appointment of Dr. Karen Smith, an accomplished drug development executive, to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
